Inhibition of iron uptake from iron salts and chelates by divalent metal cations in intestinal epithelial cells.
Iron chelates, namely, ferrous bisglycinate and ferric EDTA, are promising alternatives to iron salts for food fortification. The objectives of this study were to compare iron uptake from radiolabeled ferrous sulfate, ferrous ascorbate, ferrous bisglycinate, ferric chloride, ferric citrate, and ferric EDTA by Caco-2 cells with different iron status and in the presence of divalent metal cations. Iron-loaded Caco-2 cells, with reduced DMT-1 and elevated HFE mRNA levels, down-regulated uptake from ferrous ascorbate and bisglycinate but not from ferric compounds. Nevertheless, iron uptake from all compounds was markedly inhibited in the presence of 100-fold molar excess of Co2+ and Mn2+ cations, with ferrous compounds showing a greater percent reduction. Our results suggest that ferrous iron is the predominant form of iron taken up by intestinal epithelial cells and the DMT-1 pathway is the major pathway for uptake. Iron uptake from chelates appears to follow the same pathway as uptake from salts.
Yeung
Chi Kong
CK
Department of Food Science, Cornell University, Ithaca, New York 14853, USA.
Glahn
Raymond P
RP
Miller
Dennis D
DD
D018938:Caco-2 Cells; D002413:Cations, Divalent / Q000494:pharmacology*; D003035:Cobalt / Q000494:pharmacology; D020895:Enterocytes; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism; D005290:Ferric Compounds / Q000378:metabolism; D005296:Ferrous Compounds / Q000378:metabolism; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000737:chemistry / Q000187:drug effects*; D007501:Iron / Q000378:metabolism*; D007502:Iron Chelating Agents / Q000378:metabolism; D008345:Manganese / Q000494:pharmacology
D002413:Cations, Divalent; D005290:Ferric Compounds; D005296:Ferrous Compounds; D007502:Iron Chelating Agents; D003035:Cobalt; D008345:Manganese; D007501:Iron